Panalgo, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Panalgo, LLC - overview

Established

1996

Location

Waltham, MA, US

Primary Industry

Healthcare IT

About

Panalgo, LLC provides innovative analytics solutions focused on enhancing operational efficiency and decision-making in the healthcare and pharmaceutical sectors, leveraging advanced technology for optimal workflow processes. Founded in 1996 in Waltham, US, Panalgo specializes in healthcare analytics solutions. The company was acquired by Managed Markets Insight & Technology, LLC in September 2021 from Silversmith Capital Partners and Transformation Capital, with specific financial terms undisclosed. Mike Sherbun, one of the founders, has a history of entrepreneurship in technology and analytics.


Panalgo specializes in delivering tailored analytics solutions that address the diverse needs of its clients. The company's primary offerings include advanced technology systems designed to enhance operational efficiency across sectors such as healthcare, finance, and logistics. These systems optimize workflow processes, improve data management, and streamline communication among end-users, with a customer base that includes large enterprises and small to medium-sized businesses throughout North America, Europe, and Asia-Pacific. Panalgo generates revenue through a structured B2B model, focusing on long-term client relationships that facilitate ongoing support and service agreements.


Revenue streams include subscription-based services for software solutions and one-time purchases of technology systems. The company’s flagship products play a crucial role in its revenue strategy, attracting significant interest and designed to meet the tailored needs of businesses in various sectors. Following the acquisition in September 2021, Panalgo aims to enhance its product offerings and expand into new geographic markets. The recent funding from the acquisition will be used to improve the speed and reliability of analytics in pharmaceutical decision-making.


Specific upcoming product launches or timelines have not been detailed, but the focus remains on leveraging the acquisition to bolster its position in the healthcare analytics space, ultimately aiming for broader market penetration.


Current Investors

Hg, Welsh, Carson, Anderson & Stowe, Managed Markets Insight & Technology, LLC/Evaluate Ltd.

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Analytics & Performance Software, Medical Software

Website

www.bhei.com

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Panalgo, LLC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedPanalgo, LLC-
GrowthCompletedPanalgo, LLC-

Displaying 1 - 2 of 2

Panalgo, LLC - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.